Contact Us
Contact Us

For Partners

SCRI is the only oncology research organization of its kind to offer end-to-end clinical trial site management, contract research services for biopharma and personalized medicine advisory services in one place. As a leader in drug development, SCRI has conducted nearly 750 first-in-human trials to date. More than 4,500 patients enroll to our early and late-phase trials every year.

Scientific Key Opinion Leaders

Faculty of physicians who oversees optimal execution of all aspects of clinical research

Learn More

Oncology-Focused CRO

Designs and deploys trials to sites to assess and monitor the safety and efficacy of new treatments

Learn More

Centralized SMO

Oversees a network of sites where physicians enroll and treat patients on clinical trials with full trial operations support

Learn More

Personalized Medicine

Informs targeted treatment and trial strategies for patients based on real-world data

Learn More

Scientific Key Opinion Leaders

Our world-renowned physician research leaders, trained at the top academic institutions, deliver valuable insights into the optimal execution of all aspects of clinical research.

Meet Our Leadership Team

Oncology-Focused Contract Research Organization (CRO):

Contracted by biopharma to design, manage and monitor trials as well as analyze results

From Pre-Clinical to Post-Approval, SCRI Development Innovations delivers end-to-end CRO capabilities:

  • As a part of SCRI, we leverage expert physician expertise to design and implement clinical trials to advance therapies and improve the lives of patients fighting cancer.
  • We work in tandem with SCRI’s centralized SMO to design and deliver timely site activation, patient recruitment and overall study delivery.
  • Powered by Genospace’s precision medicine technology, our personalized medicine expertise informs clinical development approaches every step of the way.
 
Oncology Expertise in the Following Areas:
  • Clinical Development
  • Strategic Planning & Oversight
  • Clinical Monitoring
  • Medical Monitoring
  • Medical Writing & Publishing
  • Pharmacovigilance
  • Regulatory Affairs
  • Data Management
  • Project Management
  • Biostatistics
 

Differentiators:

  • Strategic Site Relationship & Expedited Start-up – We’re able to leverage existing relationships and infrastructure with SCRI sites to achieve expedited start-up in as little as 6 weeks
  • Unique Personalized Medicine & Data Capabilities – SCRI’s Personalized Medicine program offers scientific consultative services to drug development partners to enrich clinical development insights

385+

trials conducted to date

  • 47 Active Industry Sponsored Trials
  • 28 Active Investigator Initiated Trials

55+

first-in-human trials conducted

25+

first-in-class trials conducted

CRO with Roots in Cancer since 2006

Interested in Partnering with SCRI?

Contact Us

Read how our partnerships advance science and transform care.

Newsroom

Centralized Site Management Organization:

Partner with a network of sites where physicians enroll and treat patients on clinical trials:

  • SCRI’s Site Management Organization (SMO) offers operational and other centralized research support services for sites on phase I through III industry-sponsored and investigator-initiated trials.
  • The SMO offers support services for trials across tumor types including highly specialized expertise in complex GI, lung, breast/gynecologic, central nervous system, genitourinary, melanoma and blood cancers. Additionally, the SMO works with FACT-accredited transplant sites to advance cellular therapy research inclusive of CAR T-Cell, CRISPR and other novel approaches.

SCRI Centralized Site Support Services

Menu management & accelerated start up

Regulatory

Budget, contract, and financial services

Protocol operations

Global quality & education

Technology integration & support

Financial planning & analysis

Our Differentiators:

 

SMO differentiators generic flow chart
  • Rapid study activation timelines
  • Community clinic-based model at SCRI sites provides access to larger numbers of patients
  • Efficiencies with budget, contract, and informed consent
  • Utilization of central IRBs
  • Standardized SOPs and quality metrics across all SCRI sites
  • Partners with the Personalized Medicine team to rapidly identify patients for trials
 

 

Personalized Medicine

Leverages real-world data to advise physicians and biopharma on clinical development and treatment planning

Leverages patient data to inform clinical development patient strategies

  • Powered by cloud-based precision medicine technology developed by Genospace that transforms patient data into actionable insights
  • Informs trial design, trial matching, optimal treatment recommendations for patients and population diversification

Genospace combines rich data sources with powerful technology to make biomedical data useful and usable, enabling the convergence of clinical research and clinical care.

Learn More About Genospace

 

Personalized Medicine Program Includes:

Site Support

  • Patient-Centric Clinical Trial Matching
  • Molecular Cancer Conferences: SCRI’s Molecular Tumor Boards
  • MolecularHelp Consultation: On Demand Reviews of NGS Reports
  • Molecular Education
  • Variant Annotation
  • Clinical Trial incl/excl criteria
  • Drug MOA sensitivity

Partner Support

  • Feasibility Analysis
  • Real World Data Analytics
  • Data-driven Study Design
  • On Study Analytics
  • Scientific Consultative Services

Contact Us

Email
top